10月30日晚，珀莱雅化妆品股份有限公司（603605.SH）发布第三季度财务报告。报告显示，2025年前三季度珀莱雅实现营业收入70.98亿元， 同比增长1.89%，归母净利润10.26亿元，同比增长2.65%；实现扣非净利润9.98亿元，同比增长2.72%，三项核心盈利指标均保持同比正增长。 盈利质量方面，2025年前三季度毛利率与净利率较上年同期均实现提升。其中，毛利率达73.69%，较2024年同期的70.07%增长3.62个百分点， 净利率为14.86%，盈利质量与盈利能力实现协同升级。 旗舰品牌核心稳固，多品牌协同发力 业绩增长的背后，是珀莱雅"核心稳固、新锐增长"的多品牌战略持续落地见效。珀莱雅品牌凭借多年积累的市场口碑与产品实力，持续巩固护 肤赛道优势，通过"双抗系列""红宝石系列"等迭代，契合消费者需求，为整体营收提供支撑；同时，公司多品牌潜力加速释放，彩棠、 Off&Relax、原色波塔等品牌依托品牌的差异化定位实现突破，悦芙媞则在年轻消费群体中持续渗透，多品牌间的品类互补与客群分层，既拓 宽了珀莱雅市场覆盖范围，也为长期增长注入多元动力。 今年以来，珀莱雅在研发领域有多个动作。7月，珀莱 ...

当PDRN成分席卷美妆市场时，与之相关的14大衰老标志之一的「线粒体抗衰」却仍未迎来爆发时刻。这座掌控95%细胞能量的「生命工厂」，为何难以叩 开消费者的认知大门？但美妆巨头们的科研竞赛，正把战场推向细胞能量的最深处。 深度科普：线粒体功能障碍如何导致皮肤衰老？ 在微观的世界里，线粒体的"一呼一吸"对皮肤乃至整个人体的健康产生重要的影响。 早在2013年，《Cell》期刊便将"线粒体功能障碍"列为衰老的九大标志物之一，推动其研究从狭义的线粒体DNA（mtDNA）遗传病拓展至广义的与线粒体功 能障碍相关的疾病谱研究。线粒体作为皮肤细胞的能量工厂，为细胞活动提供95%的能量货币ATP，而皮肤抗氧化的核心——自由基（ROS）同样是能量生 产活动的副产物。 但想要入局线粒体抗老这一前沿技术赛道，首先要了解线粒体的工作和生存机制。 作为细胞呼吸的关键参与者和能量生产的"能量工厂"，双膜结构细胞器——线粒体对于维持细胞生存和发挥正常生理作用至关重要。 线粒体通过电子传递链（ETC）和三羧酸循环，将有机物质如葡萄糖等被氧化产生大量的三磷酸腺苷（Adenosine Triphosphate，ATP）[1]。 同时，线粒体还有 ...

东方证券研报指出，作为IFSCC金级战略合作伙伴，珀莱雅日前携14项科研成果重磅亮相，更凭借一项 具有突破意义的线粒体抗衰研究，成功摘得" IFSCC2025 十大基础研究奖"，成为本年度唯一获此奖项 的中国化妆品企业，也是至今中国企业在世界化妆品比赛中取得的最好成绩。近期公司对外投资的节奏 有所加快，未来全球化投资布局将成为公司迈向行业巨头的重要抓手。该行认为公司目前走在正确的战 略道路上，而目前市场估值建立在短期经营的悲观假设之上，因此该行提示对公司的左侧布局机会。无 论是新管理团队的组建，还是研发的持续投入、对外投资的加快还是H股的启动，认为公司经营都走在 正确的战略轨道中，对公司中期保持可持续较快增长抱有信心。对公司维持2025-2027 年每股收益分别 为4.44、5.13 和5.88元的预测， DCF目标估值116.85元，维持"买入"评级。 ...

Core Insights - The company Proya has won the "IFSCC 2025 Top Ten Basic Research Award," becoming the only Chinese cosmetics company to receive this honor, highlighting the international recognition of China's beauty research capabilities [1][8] - Proya's research, conducted in collaboration with Zhejiang University, utilized AI-driven deep learning technology to efficiently screen bioactive compounds that enhance mitochondrial function and prevent skin aging [3][5] - The research led to the development of the anti-aging compound formula Cellergy pro™, which significantly improves energy metabolism in damaged cells and repairs mitochondrial abnormalities [3][5] Research and Development - Proya's research team, led by Dr. Wei Jihua, presented their findings at the IFSCC conference, showcasing a deep learning-aided screening platform that automates the analysis of mitochondrial dynamics and function [5] - The company has established collaborations with top institutions, including Zhejiang University and the University of Innsbruck, to explore mitochondrial function regulation and its relationship with aging pathways [6] - Proya aims to create original active ingredient screening models and develop high-quality self-researched raw materials, integrating advanced technologies into product development [6] Future Directions - The founder and chairman of Proya, Hou Junchen, emphasized the importance of scientific innovation and global research system investment as key drivers for the company's future [8] - Proya plans to continue its technology-driven and internationalization strategy to enhance its core competitiveness and promote high-quality development in Chinese beauty [8] - The Chief Scientific Officer, Huang Hu, noted that the award represents one of the highest accolades received by the Chinese research team in the history of IFSCC, reinforcing the commitment to empower Chinese brands on the global stage [8]

Core Viewpoint - The article discusses the potential of domestic brands to lead the market in the precise anti-aging sector, particularly in the context of mitochondrial function and the innovative use of PDRN technology [2][3]. Group 1: Product Innovation - Baihong Group's brand Zhanmeya launched a new product, the "Ball PDRN Super Cream," which targets mitochondrial function for anti-aging [3][5]. - The product utilizes a proprietary technology called Mit o-S-PDRN™, which encapsulates PDRN in microspheres to enhance skin absorption and efficacy [13][14]. Group 2: Scientific Basis - Mitochondrial dysfunction is identified as a significant marker of aging, with studies indicating its role in skin aging processes [7][9]. - PDRN is highlighted as a key ingredient that can repair mitochondrial damage and enhance cellular energy production [12][15]. Group 3: Efficacy and Testing - The Ball PDRN Super Cream reportedly increases ATP levels in skin cells by 197.62%, significantly higher than similar products [19]. - Efficacy tests show that the cream can reduce crow's feet wrinkles by 41.87% and improve collagen production significantly over four weeks [20]. Group 4: Market Position and Strategy - Zhanmeya aims to establish itself as a leader in the PDRN market, having already achieved significant sales success with its previous product, the Ball PDRN Energy Stick [25][26]. - The brand is positioned to leverage its scientific research background to innovate further in the anti-aging skincare segment [24][28].

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][29]. Core Insights - The beauty care sector is highlighted with the launch of the world's first "honeycomb collagen" gel product by Jinbo Biological, which shows significant advancements in cell adhesion and collagen retention [3][23]. - The report notes a general increase in the performance of retail, social services, and beauty care sectors, with respective weekly gains of +2.65%, +2.30%, and +5.42% [14][16]. - Key companies such as Proya and Huaxi Hospital are collaborating on mitochondrial anti-aging research, indicating a trend towards scientific advancements in beauty products [3][23]. Summary by Sections Market Performance - For the week of July 21-25, 2025, the retail, social services, and beauty care sectors saw increases of +2.65%, +2.30%, and +5.42%, ranking 14th, 17th, and 6th among 31 primary industries [14][16]. - Sub-sectors such as personal care products, tourism, and cosmetics experienced notable gains of +7.74%, +3.93%, and +3.39% respectively [16][19]. Key Industry Events and News - The National Development and Reform Commission announced that the Hainan Free Trade Port will officially close on December 18, 2025, which is expected to enhance trade conditions [3][23]. - Jinbo Biological launched a new injectable collagen gel product, which is expected to significantly improve skin treatment outcomes [3][23]. - Proya and Huaxi Hospital have partnered to focus on mitochondrial anti-aging research, which may lead to innovative product developments [3][23]. Investment Recommendations - The report recommends focusing on companies within the beauty care, IP derivatives, and gold jewelry sectors, suggesting specific stocks such as Proya, Giant Biological, and Marubi [5][29]. - The report emphasizes the potential for growth in these sectors, particularly in light of recent product innovations and market trends [5][29].